Santhera Pharmaceuticals Holdings.../ CH1276028821 /
2024-02-22 6:23:09 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
11.7000USD | - | 300 Turnover: 3,510 |
-Bid Size: - | -Ask Size: - | 112.42 mill.USD | - | - |
GlobeNewswire
1:30 PM
Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates
GlobeNewswire
1:30 PM
C-Bond Systems to File its Form 10-K on April 1, 2024, and Hold Conference Call to Discuss its Finan...
GlobeNewswire
1:21 PM
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
GlobeNewswire
1:12 PM
Cloud Mining Platform Blueskyminer Offers an Avenue for Fixed Income with Cryptocurrency
Newsfile Corp
1:12 PM
EchoGlobal Tech, Ukrainian IT Staffing Agency, Achieves 51% Revenue Growth Despite Impact of War
GlobeNewswire
1:00 PM
BurgerFi to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
GlobeNewswire
1:00 PM
CoinRaffle.io Unveils Innovative Platform for Secure and Fair Decentralized Raffles
GlobeNewswire
1:00 PM
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
1:00 PM
Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update
GlobeNewswire
12:30 PM
EVOLV TECHNOLOGIES HOLDINGS, INC. (NASDAQ: EVLV) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds I...
Newsfile Corp
11:59 AM
Acqua Funding Announces Launch of Innovative Real Estate Learning Platform in April, Bridging Knowle...